Scott A Tomlins
Adjunct Associate Professor of Pathology
Medical School
[email protected]
Available to mentor
Scott A Tomlins
Adjunct Associate Professor
Manage Your Profile
Center Memberships
-
Center MemberTaubman Institute
-
Center MemberCenter for Computational Medicine and Bioinformatics
-
Center MemberRogel Cancer Center
Recent Publications
-
Cani A, Tomlins SA, Johnson B, Bush S, Nitchie MD, Robinson KM, Inman J, White R, Plouffe K, Rhodes DR, Cobain EF. Journal of Clinical Oncology, 2025 May 30; 43 (16):Proceeding / Abstract / PosterAntibody drug conjugates treatment response score (ADC TRS) for sequencing trastuzuamb deruxtecan (T-DXd) and sacituzumab govitecan (SG) in advanced breast cancer (aBC).
-
Liu M, Jagodinsky JC, Callahan SC, Minne RL, Johnson DB, Tomlins SA, Iyer G, Baschnagel AM. JCO Precision Oncology, 2025 Feb 1; 9:Journal ArticleGenomic and Immune Landscape of Non-Small Cell Lung Cancer Brain Metastases
DOI:10.1200/PO-24-00690 PMID: 39983077 -
Smith SC, Melson JW, Quillin JM, Hiemenz MC, Tomlins SA, Wobker SE. Am J Clin Pathol, 2025 Jan 22;Journal ArticleA pathologist's primer on implementing new standard-of-care molecular biomarker testing for precision prostate cancer management.
DOI:10.1093/ajcp/aqae186 PMID: 39838622 -
Szczepanski JM, Chapel DB, Huang T, Pham T, Mannan R, Mehra R, Sciallis AP, Tomlins S, Skala SL, Udager AM. International Journal of Gynecological Pathology, 2025 Jan 1;Journal ArticleThe Morphologic and Molecular Heterogeneity of Fumarate Hydratase-deficient Leiomyomas: Integrative Molecular Profiling of Uterine Smooth Muscle Tumors With Histologic Feature Correlation
DOI:10.1097/PGP.0000000000001101 -
Singhal U, Nallandhighal S, Tosoian JJ, Hu K, Pham TM, Stangl-Kremser J, Liu CJ, Karim R, Plouffe KR, Morgan TM, Cieslik M, Lucianò R, Shariat SF, Finocchio N, Dambrosio L, Doglioni C, Chinnaiyan AM, Tomlins SA, Briganti A, Palapattu GS, Udager AM, Salami SS. Nature Communications, 2024 Dec 1; 15 (1):Journal ArticleIntegrative multi-region molecular profiling of primary prostate cancer in men with synchronous lymph node metastasis
DOI:10.1038/s41467-024-48629-y PMID: 38773085 -
Oakley B, Moon J, Connolly M, Burkard ME, Suga JM, Thomas S, Bulen BJ, Lamb LE, Khazanov NA, Hovelson D, Vakil H, Dusenbery A, Mowers J, Kwiatkowski K, Johnson DB, Rhodes DR, Tomlins SA, Safa M. Journal of Thoracic Oncology, 2024 Jul 10; 19 (7): e47Journal ArticlePP01.106 Validation of Immunotherapy Response Score (IRS) for Predicting Pembrolizumab Monotherapy Benefit in First Line (1L) Non-small cell lung cancer (NSCLC)
DOI:10.1016/j.jtho.2024.05.333 -
Thomas SP, Habel LA, Suga JM, Achacoso N, Nugent J, Robinson KM, White R, Inman J, Plouffe K, Kwiatkowski K, Johnson B, Rhodes DR, Tomlins SA. Journal of Clinical Oncology, 2024 Jun 19; 42 (16_suppl): 3140 - 3140.Journal ArticleEvaluation of a predictive biomarker for antibody drug conjugates (ADCs).
DOI:10.1200/jco.2024.42.16_suppl.3140 -
Lamb L, Mowers J, Nasrazadani A, Burkard M, Khazanov N, Hovelson D, Kwiatkowski K, Tomlins S, Johnson DB, Rhodes D. Cancer Research, 2024 May 6; 84 (9_Supplement): po1-14-04-po1-14-04Journal ArticleAbstract PO1-14-04: A multivariate biomarker to guide antibody-drug conjugate selection and provide insight on response differences across breast cancer subtypes
DOI:10.1158/1538-7445.sabcs23-po1-14-04
